TSPT Key Stats
|Revenue (Quarterly YoY Growth)||-95.52%|
|EPS Diluted (TTM)||-1.522|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||-28.46M|
|Gross Profit Margin (Quarterly)||81.62%|
|Profit Margin (Quarterly)||-1005%|
|Dividend Yield (TTM)||0%|
|Payout Ratio (TTM) Pro||Go Pro|
- Transcept Pharma (TSPT) Notes ISS Support Against Stockholder Group Street Insider Dec 11
- 2:18 am Transcept Pharma provides update on key initiatives to increase shareholder value Dec 5
- TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 5
- Transcept Pharmaceuticals Provides Update to Key Initiatives Being Undertaken to Increase Stockholder Value noodls Dec 4
- 4 Healthcare Stock Stories Making Midweek Headlines Nov 13
- TRANSCEPT PHARMACEUTICALS INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Direct Nov 13
- Transcept Pharmaceuticals Announces Plans to Reduce Expenses Through a Reduction in Force and a Restructuring of its Board of Directors noodls Nov 13
- Transcept Pharma (TSPT) to Eliminate 43% of Workforce; Will Explore Options Street Insider Nov 13
- 4 Stocks Under $10 Making Big Moves Oct 11
- Transcept Pharma (TSPT) Responds to Request by Retrophin to Acquire Up to 15% Stake Street Insider Sep 30
TSPT Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Transcept Pharmaceuticals is down 32.33% over the last year vs S&P 500 Total Return up 27.25%, Vertex up 54.01%, and Achillion Pharmaceuticals down 60.27%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for TSPT
Pro Strategies Featuring TSPT
Did Transcept Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience.